Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kari Chansky

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Annals of the New York Academy of Sciences|July 15, 2004
Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapyTatsuo Kimura, Will S Holland, Tomoya Kawaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712Angela M Davies, Kari Chansky, Derick H M Lau, et al.
American Journal of Clinical Oncology|September 23, 2009
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomachCharles D Blanke, Kari Chansky, Kathy L Christman, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003Philip C Mack, Mary W Redman, Kari Chansky, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 9, 2004
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitroHoward A Chansky, Fariba Barahmand-Pour, Qi Mei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2009
The IASLC Lung Cancer Staging Project: data elements for the prospective projectDorothy J Giroux, Ramón Rami-Porta, Kari Chansky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural MesotheliomaDavid Rice, Kari Chansky, Anna Nowak, et al.
Leukemia & Lymphoma|December 5, 2017
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphomaAndy I Chen, Jessica T Leonard, Craig Y Okada, et al.
Head & Neck|December 4, 2003
Postradiotherapy surveillance practice for head and neck squamous cell carcinoma--too much for too little?David L Schwartz, Jerry Barker, Kari Chansky, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Annals of the New York Academy of Sciences|July 15, 2004
Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapyTatsuo Kimura, Will S Holland, Tomoya Kawaguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712Angela M Davies, Kari Chansky, Derick H M Lau, et al.
American Journal of Clinical Oncology|September 23, 2009
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomachCharles D Blanke, Kari Chansky, Kathy L Christman, et al.
Clinical Lung Cancer|August 6, 2013
Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapyKaren Kelly, Kari Chansky, Philip C Mack, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003Philip C Mack, Mary W Redman, Kari Chansky, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|June 9, 2004
Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitroHoward A Chansky, Fariba Barahmand-Pour, Qi Mei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 23, 2009
The IASLC Lung Cancer Staging Project: data elements for the prospective projectDorothy J Giroux, Ramón Rami-Porta, Kari Chansky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2016
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural MesotheliomaDavid Rice, Kari Chansky, Anna Nowak, et al.
Leukemia & Lymphoma|December 5, 2017
Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphomaAndy I Chen, Jessica T Leonard, Craig Y Okada, et al.
Head & Neck|December 4, 2003
Postradiotherapy surveillance practice for head and neck squamous cell carcinoma--too much for too little?David L Schwartz, Jerry Barker, Kari Chansky, et al.
Pageof 7